Literature DB >> 7927227

Prospective randomized trial of emergency portacaval shunt and emergency medical therapy in unselected cirrhotic patients with bleeding varices.

M J Orloff1, R H Bell, M S Orloff, W G Hardison, A G Greenburg.   

Abstract

A prospective randomized trial was conducted in unselected, consecutive patients with bleeding esophageal varices resulting from cirrhosis comparing (1) emergency portacaval shunt performed within 8 hr of initial contact (21 patients) with (2) emergency medical therapy (intravenous vasopressin and esophageal balloon tamponade) followed in 9 to 30 days by elective portacaval shunt in survivors (22 patients). All patients underwent the same diagnostic workup within 3 to 6 hr of initial contact, and received identical supportive therapy initially. All patients were followed up for at least 10 yr. The protocol contained no escape or cross-over provisions. There were no statistically significant differences between the two treatment groups in the incidence of any of the clinical variables, results of laboratory tests or degree of portal hypertension. Child's risk classes in the shunt group were A-2 patients, B-8 patients and C-11 patients, whereas in the medical group they were A-10 patients, B-5 patients, and C-7 patients, a significant difference (p < 0.01) that might have favored emergency medical treatment. Bleeding was controlled initially and permanently by emergency shunt in every patient, but by medical therapy in only 45% (p < 0.001). Mean requirement for blood transfusion was 7.1 +/- 2.6 units in the shunt group and 21.4 +/- 2.6 units in the medical group (p < 0.001). Eighty-one percent of the patients in the shunt group were discharged alive compared with 45% in the medical group (p = 0.027). Five- and 10-yr observed survival rates were 67% and 57%, respectively, after emergency shunt compared with 18% and 18%, respectively, after the combination of emergency medical therapy and elective shunt (p < 0.01). These survival rates produced by emergency shunt performed within 8 hr of initial contact confirm the effectiveness of this procedure observed in our previous unrandomized studies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7927227     DOI: 10.1002/hep.1840200414

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

Review 1.  Acute variceal bleeding: general management.

Authors:  D Patch; L Dagher
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

Review 2.  Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis.

Authors:  S Khan; C Tudur Smith; P Williamson; R Sutton
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

3.  Portal hypertension--the surgical pendulum.

Authors:  J M Henderson
Journal:  West J Med       Date:  1995-06

4.  Alcoholic versus nonalcoholic cirrhosis in a randomized controlled trial of emergency therapy of bleeding varices.

Authors:  Marshall J Orloff; Jon I Isenberg; Henry O Wheeler; Kevin S Haynes; Horacio Jinich-Brook; Roderick Rapier; Florin Vaida; Robert J Hye; Susan L Orloff
Journal:  J Surg Res       Date:  2010-12-03       Impact factor: 2.192

5.  Portal vein thrombosis in cirrhosis with variceal hemorrhage.

Authors:  M J Orloff; M S Orloff; S L Orloff; B Girard
Journal:  J Gastrointest Surg       Date:  1997 Mar-Apr       Impact factor: 3.452

6.  Randomized controlled trial of emergency transjugular intrahepatic portosystemic shunt versus emergency portacaval shunt treatment of acute bleeding esophageal varices in cirrhosis.

Authors:  Marshall J Orloff; Florin Vaida; Kevin S Haynes; Robert J Hye; Jon I Isenberg; Horacio Jinich-Brook
Journal:  J Gastrointest Surg       Date:  2012-09-25       Impact factor: 3.452

7.  Surgical portosystemic shunts in the era of TIPS and liver transplantation are still relevant.

Authors:  Ilia Gur; Brian S Diggs; Susan L Orloff
Journal:  HPB (Oxford)       Date:  2013-08-20       Impact factor: 3.647

Review 8.  Current state of portosystemic shunt surgery.

Authors:  Martin Wolff; Andreas Hirner
Journal:  Langenbecks Arch Surg       Date:  2003-03-29       Impact factor: 3.445

9.  Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis.

Authors:  Danielle Roberts; Lawrence Mj Best; Suzanne C Freeman; Alex J Sutton; Nicola J Cooper; Sivapatham Arunan; Tanjia Begum; Norman R Williams; Dana Walshaw; Elisabeth Jane Milne; Maxine Tapp; Mario Csenar; Chavdar S Pavlov; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2021-04-10

10.  Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis.

Authors:  Rosa G Simonetti; Giovanni Perricone; Helen L Robbins; Narendra R Battula; Martin O Weickert; Robert Sutton; Saboor Khan
Journal:  Cochrane Database Syst Rev       Date:  2020-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.